arcadia

SUVEN LIFE SCIENCES LTD.

NSE : SUVENBSE : 530239ISIN CODE : INE495B01038Industry : Pharmaceuticals & DrugsHouse : Private
BSE272.201.65 (+0.61 %)
PREV CLOSE ( ) 270.55
OPEN PRICE ( ) 270.55
BID PRICE (QTY) 272.50 (22)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 64365
TODAY'S LOW / HIGH ( )260.35 280.35
52 WK LOW / HIGH ( )173.3 337.7
NSE272.301.55 (+0.57 %)
PREV CLOSE( ) 270.75
OPEN PRICE ( ) 270.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 272.30 (50)
VOLUME 553761
TODAY'S LOW / HIGH( ) 260.00 280.65
52 WK LOW / HIGH ( )174.25 337.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 09-03 1989
Management Info
Venkateswarlu Jasti - Chairman - Managing Director
Registered Office

Address 8-2-334, S D E Serene Chambers,6th Floor, Road No 5, Avenue 7,Banjara Hills,
Hyderabad,
Telangana-500034

Phone +91-40- 23541142 23543311 32921695 32921696

Email info@suven.com

Website www.suven.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
16Apr Dr. Reddys Lab, Majesco and Cipla to s
Dr. Reddys Laboratories has received the Establishment Inspection Report..
16Apr Suven Life Science gains on getting no
Suven Life Sciences is currently trading at Rs. 272.75, up by 2.65 point..
15Apr Suven Life Science gets nod from US ba
Suven Life Science has received approval from a US bankruptcy court to b..
15Apr Suven Life Science gets nod to enhance
Suven Life Science’s board has approved the enhancement of investment li..
04Apr Suven Life Sciences secures product pa
Suven Life Sciences has been granted one product patent from Israel, one..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit252.331584.27
Gross Profit 352.2 2302.66
Operating Profit 413.582561.87
Net Sales 1290.216252.57
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Hester Biosciences (BSE)
 1487.50 (2.00%)
M.Cap ( in Cr)1265.40
Ipca Laboratories (BSE)
 968.95 (2.98%)
M.Cap ( in Cr)12242.89
Shilpa Medicare (BSE)
 398.70 (5.98%)
M.Cap ( in Cr)3250.48
Fredun Pharma (BSE)
 473.35 (3.60%)
M.Cap ( in Cr)188.85
Themis Medicare (BSE)
 297.45 (3.59%)
M.Cap ( in Cr)273.09
Shareholding Pattern
PROMOTERS 60%
NON-INSTITUTION 31.85%
MUTUAL FUNDS/UTI 1.66%
FI/BANKS/INSURANCE 0.31%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM